Company / Operating Cash Flow per Share
Wave Life Sciences Ltd. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.23
FY2025
5-year range
-$2.38 / -$0.22
FY2021-FY2025
Trend
+3.3%
vs FY2024
Sector context
#121 of 212
Health Care
What the data says
At $-1.23, Wave Life Sciences Ltd.'s operating cash flow per share ranks #121 of 212 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-5.48 in FY2020 to $-0.22 in FY2023.
Based on SEC 10-K filings.
-1.23 in FY2025.
Declined from $-0.22 to $-1.23 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#121 of 212 in Health CareTop 57% of 212This company -$1.23 Sector average -$14.72
▼
+91.7% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 3.3% year-over-year.
- Ranks #121 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.23 | +3.3% |
| FY2024 | -$1.27 | -467.0% |
| FY2023 | -$0.22 | +85.0% |
| FY2022 | -$1.49 | +37.5% |
| FY2021 | -$2.38 | +56.6% |
| FY2020 | -$5.48 | -93.1% |
| FY2019 | -$2.84 | -245.6% |
| FY2018 | -$0.82 | +76.9% |
| FY2017 | -$3.56 | -140.3% |
| FY2016 | -$1.48 | -77.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026